basiliximab
SpainDrugs containing this active substance
-
It is used in adults, adolescents, and children undergoing a kidney transplant to help prevent the body from rejecting the new organ during the first 4 to 6 weeks after surgery.
Form: powder and solvent for solution for injection
Active substance Dosage basiliximab 20 mg Manufacturer: Novartis Europharm Limited